WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
93.32
-1.28 (-1.35%)
Feb 4, 2026, 11:30 AM CST
68.57%
Market Cap282.13B +88.4%
Revenue (ttm)43.88B +23.2%
Net Income14.99B +85.9%
EPS4.65 +53.2%
Shares Out2.96B
PE Ratio18.72
Forward PE15.46
Dividend0.70 (0.75%)
Ex-Dividend DateSep 26, 2025
Volume14,543,675
Average Volume46,291,897
Open94.00
Previous Close94.60
Day's Range92.82 - 94.50
52-Week Range48.48 - 115.79
Beta0.67
RSI44.62
Earnings DateMar 24, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 37,832
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements